More Info
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.
$85.00
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.
CJC-1295 + IPA is a research peptide combination formulated for laboratory investigation into growth hormone (GH) secretion, recovery, body composition, and healthy aging. This synergistic blend combines CJC-1295, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin (IPA), a selective growth hormone secretagogue, to study their complementary effects on the body’s natural GH release.
Researchers investigate this combination for its potential to support lean muscle development, fat metabolism, tissue repair, exercise recovery, sleep quality, and overall metabolic function. CJC-1295 + IPA is widely studied in preclinical research exploring performance optimization, regenerative medicine, and endocrine health.
This product is intended strictly for laboratory and scientific research purposes only. It is not intended for human consumption or veterinary use.
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.
Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.
CJC-1295 + IPA is a research peptide combination formulated for laboratory investigation into growth hormone (GH) secretion, recovery, body composition, and healthy aging. This synergistic blend combines CJC-1295, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin (IPA), a selective growth hormone secretagogue, to study their complementary effects on the body’s natural GH release.
Researchers investigate this combination for its potential to support lean muscle development, fat metabolism, tissue repair, exercise recovery, sleep quality, and overall metabolic function. CJC-1295 + IPA is widely studied in preclinical research exploring performance optimization, regenerative medicine, and endocrine health.
This product is intended strictly for laboratory and scientific research purposes only. It is not intended for human consumption or veterinary use.
A combination of a GHRH analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin), studied together in research for their synergistic effect on growth hormone release.




Reviews
There are no reviews yet.